A Progressive Early Mobilization Program Is Significantly Associated With Clinical and Economic Improvement: A Single-Center Quality Comparison StudyKeibun Liu, Takashi Mato, Hiroaki Ohtake et al.|Critical Care Medicine|2019Cited by 43
The safety of a novel early mobilization protocol conducted by ICU physicians: a prospective observational studyKeibun Liu, Takashi Mato, Alan Kawarai Lefor et al.|Journal of Intensive Care|2018Cited by 41
Development of a Novel Anti-CD44 Variant 7/8 Monoclonal Antibody, C44Mab-34, for Multiple Applications against Oral CarcinomasHiroyuki Suzuki, Yukinari Kato|Biomedicines|2023Cited by 15
A Novel Anti-CD44 Variant 3 Monoclonal Antibody C44Mab-6 Was Established for Multiple ApplicationsHiroyuki Suzuki, Yukinari Kato|International Journal of Molecular Sciences|2023Cited by 14
Development of a Novel Anti-CD44 Variant 4 Monoclonal Antibody C44Mab-108 for ImmunohistochemistryHiroyuki Suzuki, Yukinari Kato|Current Issues in Molecular Biology|2023Cited by 14